A myxoma virus intergenic transient dominant selection vector

References

1. Bertholet C., Drillien R., Witter R. 1985; One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proceedings of the National Academy of Sciences, U.S.A. 82:2096–2100
   [Google Scholar]
2. Bouvier M. 1954; Quelques remarques sur la myxomatose. Epizootie de 1949 au Brésil (région de Campinas, est Sao-Paulo). Bulletin de l’Office International des Epizooties 46:76–77
   [Google Scholar]
3. Boyle D. B., Coupar B. E. H. 1988; A dominant selectable marker for the construction of recombinant poxviruses. Gene 65:123–128
   [Google Scholar]
4. Buller R. M. L., Smith G. L., Cremer K., Notkins A. L., Moss B. 1985; Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature, London 317:813–815
   [Google Scholar]
5. Buller R. M. L., Chakrabarti S., Cooper J. A., Twardzik D. R., Moss B. 1988; Deletion of the vaccinia virus growth factor gene reduces virus virulence. Journal of Virology 62:866–874
   [Google Scholar]
6. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5:3403–3409
   [Google Scholar]
7. Coupar B. E. H., Andrew M. E., Both G. W., Boyle D. B. 1986; Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune system. European Journal of Immunology 16:1479–1487
   [Google Scholar]
8. Davison A. J., Moss B. 1989; Structure of vaccinia virus early promoters. Journal of Molecular Biology 210:749–769
   [Google Scholar]
9. Davison A. J., Moss B. 1990; New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Research 14:4285–4286
   [Google Scholar]
10. Falkner F. G., Moss B. 1988; Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. Journal of Virology 62:1849–1854
    [Google Scholar]
11. Falkner F. G., Moss B. 1990; Transient dominant selection of recombinant vaccinia viruses. Journal of Virology 64:3108–3111
    [Google Scholar]
12. Fenner F. 1976; Classification and nomenclature of viruses. Second Report of the International Committee on Taxonomy of Viruses. Intervirology 7:1–116
    [Google Scholar]
13. Fenner F. 1983; Biological control, as exemplified by smallpox eradication and myxomatosis. Proceedings of the Royal Society of London, Series B 218:259–285
    [Google Scholar]
14. Fenner F., Ratcliffe F. N. 1965 Myxomatosis Cambridge: Cambridge University Press;
    [Google Scholar]
15. Franke C. A., Rice C. M., Strauss J. H., Hruby D. E. 1985; Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Molecular and Cellular Biology 5:1918–1924
    [Google Scholar]
16. Goebel S. J., Johnson G. P., Perkus M. E., Davis S. W., Winslow J. P., Paoletti E. 1990; The complete DNA sequence of vaccinia virus. Virology 179:247–266
    [Google Scholar]
17. Golini F., Kates J. R. 1984; Transcriptional and translational analysis of a strongly expressed early region of the vaccinia virus genome. Journal of Virology 49:459–470
    [Google Scholar]
18. Hänggi M., Bannwarth W., Stunnenberg H. G. 1986; Conserved TAAAT motif in vaccinia virus promoters: overlapping TATA box and site of transcription initiation. EMBO Journal 5:1071–1076
    [Google Scholar]
19. Herman G. E., O’Brien W. E., Beaudel A. L. 1986; An E. coli β-galactosidase cassette suitable for study of eukaryotic expression. Nucleic Acids Research 14:7130
    [Google Scholar]
20. Jackson R. J., Bults H. G. 1992; The myxoma virus thymidine kinase gene: sequence and transcriptional mapping. Journal of General Virology 73:323–328
    [Google Scholar]
21. Macaulay C., McFadden G. 1989; Tumorigenic poxviruses: characterization of an early promoter from Shope fibroma virus. Virology 172:237–246
    [Google Scholar]
22. Mackett M., Smith G. L., Moss B. 1982; Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, U.S.A. 79:7415–7419
    [Google Scholar]
23. Opgenorth A., Strayer D., Upton C., McFadden G. 1992; Deletion of the growth factor gene related to EGF and TGFα reduces virulence of malignant rabbit fibroma virus. Virology 186:175–191
    [Google Scholar]
24. Panicali D., Grzelecki A., Huang C. 1986; Vaccinia virus vectors utilizing the β-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression. Gene 47:193–199
    [Google Scholar]
25. Russell R. J., Robbins S. J. 1989; Cloning and molecular characterization of the myxoma virus genome. Virology 170:147–159
    [Google Scholar]
26. Schwer B., Visca P., Vos J. C., Stunnenberg H. G. 1987; Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5′ poly(A) leader. Cell 50:163–169
    [Google Scholar]
27. Tsao H., Liu G.-Q., Ruan L., Chu C.-M. 1988; Construction and application of plasmids containing bidirectional promoters of vaccinia virus. Journal of Virology 62:4832–4834
    [Google Scholar]
28. Upton C., Macen J. L., Wishart D. S., McFadden G. 1990; Myxoma virus and malignant fibroma rabbit virus encode a serpin-like protein important for virus virulence. Virology 179:618–631
    [Google Scholar]
29. Upton C., Macen J. L., Schreiber M., McFadden G. 1991; Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184370–382
    [Google Scholar]